BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 28825502)

  • 1. Economic evaluation of pharmacist-led medication reviews in residential aged care facilities.
    Hasan SS; Thiruchelvam K; Kow CS; Ghori MU; Babar ZU
    Expert Rev Pharmacoecon Outcomes Res; 2017 Oct; 17(5):431-439. PubMed ID: 28825502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Economic Benefits of Pharmacist Involvement in a Community Hospital-Affiliated Patient-Centered Medical Home.
    Tate ML; Hopper S; Bergeron SP
    J Manag Care Spec Pharm; 2018 Feb; 24(2):160-164. PubMed ID: 29384022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financial oversight of medication use: an expanded role for consultant pharmacists.
    Stefanacci RG
    Consult Pharm; 2012 Apr; 27(4):290-5. PubMed ID: 22498989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary evaluation of medication therapy management services in assisted living facilities in rural Minnesota.
    Scott DM; Dewey MW; Johnson TA; Kessler ML; Friesner DL
    Consult Pharm; 2010 May; 25(5):305-19. PubMed ID: 20497929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Best practices: improving patient outcomes and costs in an ACO through comprehensive medication therapy management.
    Brummel A; Lustig A; Westrich K; Evans MA; Plank GS; Penso J; Dubois RW
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1152-8. PubMed ID: 25597053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug therapy problems and medication discrepancies during care transitions in super-utilizers.
    Surbhi S; Munshi KD; Bell PC; Bailey JE
    J Am Pharm Assoc (2003); 2016; 56(6):633-642.e1. PubMed ID: 27720595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cost-consequences analysis of an adherence focused pharmacist-led medication review service.
    Desborough JA; Sach T; Bhattacharya D; Holland RC; Wright DJ
    Int J Pharm Pract; 2012 Feb; 20(1):41-9. PubMed ID: 22236179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of medication-related problems and health care provider acceptance of pharmacist recommendations in the DiabetesCARE program.
    DeName B; Divine H; Nicholas A; Steinke DT; Johnson CL
    J Am Pharm Assoc (2003); 2008; 48(6):731-6. PubMed ID: 19019801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacist review and its impact on Singapore nursing homes.
    Chia HS; Ho JA; Lim BD
    Singapore Med J; 2015 Sep; 56(9):493-501. PubMed ID: 26451051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence: An Important Metric to Assess Pharmacist Value in Quality Care.
    Campbell PJ
    J Manag Care Spec Pharm; 2019 Oct; 25(10):1044-1045. PubMed ID: 31556826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Clinical Pharmacists on Readmission Rates of Heart Failure Patients in the Accountable Care Environment.
    Schumacher C; Moaddab G; Colbert M; Kliethermes MA
    J Manag Care Spec Pharm; 2018 Aug; 24(8):795-799. PubMed ID: 30058987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving medication safety for home nursing clients: A prospective observational study of a novel clinical pharmacy service-The Visiting Pharmacist (ViP) study.
    Lee CY; Beanland C; Goeman D; Petrie N; Petrie B; Vise F; Gray J; Elliott RA
    J Clin Pharm Ther; 2018 Dec; 43(6):813-821. PubMed ID: 29770474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).
    Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ
    BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Analysis and Comparison of Medication Therapy Management Cost-Avoidance vs. Fee-for-Service Financial Models.
    Schuh MJ
    Consult Pharm; 2015 May; 30(5):291-7. PubMed ID: 25979129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and cost effectiveness of a multi-professional medication reviews in care homes (CAREMED).
    Desborough JA; Clark A; Houghton J; Sach T; Shaw V; Kirthisingha V; Holland RC; Wright DJ
    Int J Pharm Pract; 2020 Dec; 28(6):626-634. PubMed ID: 32666576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sustainable business model for comprehensive medication management in a patient-centered medical home.
    Fabel PH; Wagner T; Ziegler B; Fleming PA; Davis RE
    J Am Pharm Assoc (2003); 2019; 59(2):285-290. PubMed ID: 30611660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacy management intervention for optimizing drug therapy for nursing home patients.
    Christensen D; Trygstad T; Sullivan R; Garmise J; Wegner SE
    Am J Geriatr Pharmacother; 2004 Dec; 2(4):248-56. PubMed ID: 15903283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting Medicare Part D beneficiaries' decision to receive comprehensive medication reviews.
    Doucette WR; Zhang Y; Chrischilles EA; Pendergast JF; Newland BA; Farris KB; Frank J
    J Am Pharm Assoc (2003); 2013; 53(5):482-7. PubMed ID: 24030125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residential medication management reviews of antithrombotic therapy in aged care residents with atrial fibrillation: assessment of stroke and bleeding risk.
    Nishtala PS; Castelino RL; Peterson GM; Hannan PJ; Salahudeen MS
    J Clin Pharm Ther; 2016 Jun; 41(3):279-84. PubMed ID: 27062272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of patients' perceptions of the listening skills of the pharmacist on their willingness to re-use Home Medicines Reviews: a structural equation model.
    Carter SR; Moles R; White L; Chen TF
    Res Social Adm Pharm; 2015; 11(2):163-75. PubMed ID: 25681299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.